MICRO-X LIMITED — Call Transcript 2022

Sep 18, 2022

Micro-X Limited, ABN 21 153 273 735

==> picture [159 x 45] intentionally omitted <==

INVESTOR CALL – 9.00 AM AEST, TUESDAY 20 SEPTEMBER 2022

Discuss the A$15m strategic investment & Technology Collaboration with Varex Imaging Corporation

Adelaide, Australia, 19[th] September 2022: Australian hi-tech company Micro-X Ltd (ASX:MX1) ( Micro-X or the Company ), a leader in carbon nanotube based x-ray technology for health and security markets globally, advises that the Company will hold an Investor Call at 9.00am AEST on Tuesday, 20 September 2022 . The Company’s Managing Director, Peter Rowland will host the call with Chief Financial Officer, Kingsley Hall, to discuss the $15m strategic collaboration with Varex Imaging Corporation.

How to Access the Investor Call

To pre-register for the call, please follow the link below. A unique PIN will be provided for use when dialling into the call, which will bypass the operator and provide immediate access to the event. A recording of the call will be available on the Investor Centre section of the Company’s website for 60 days after the call.

https://s1.c-conf.com/diamondpass/10025495-dscm33.html

If participants choose to dial into the call directly, please allow additional time and dial in 10 to 15 minutes prior to the call time and enter the Conference ID: 10025495 . Dial in numbers are as follows:

Australian Toll Free: 1800 809 971 New Zealand callers: 0800 453 055 Other callers: +61 2 9007 3187

We have been advised by our conference facility provider that due to heavy call volumes at this time, participants are encouraged to use the link below to pre-register and obtain a unique PIN to access the call.

This ASX Announcement is approved by Kingsley Hall, Company Secretary of Micro-X.

– ENDS –

About Micro-X

Micro-X Limited (the Company) is an ASX listed hi-tech company developing and commercialising a range of innovative products for global health and security markets, based on proprietary cold cathode, NEX emitter technology. The electronic control of emitters with this technology enables x- ray products with significant reduction in size, weight, and power requirements, enabling greater mobility and ease of use in existing x-ray markets and a range of new and unique security and defence applications. Micro-X has a fully vertically integrated design and production facility in Adelaide, Australia. A growing technical and commercial team based in Seattle is rapidly expanding Micro-X’s US business.

Micro-X’s product portfolio is built in four, high margin, product lines in health and security. The first commercial mobile digital radiology products are currently sold for diagnostic imaging in global healthcare, military, and veterinary applications. An X-ray Camera for security imaging of Improvised Explosive Devices is in advanced development. The US Department of Homeland Security has selected Micro-X to design a next-generation Airport Checkpoint Portal with self-service x-ray. A miniature brain CT imager for pre-hospital stroke diagnosis in ambulances, is being developed with funding from the Australian Government’s Medical Research Future Fund. For more information visit: www.micro-x.com

CONTACTS

Micro-X Limited	Micro-X Investor Enquiries
Peter Rowland, Managing DirectorKingsley Hall, CFO and Company SecretaryRebecca Puddy, Head of Corporate CommunicationsTel: +61 8 7099 3966E:media@micro-x.com	David Allen / John GrangerHawkesbury PartnersTel: +61 2 9103 9494E:dallen@hawkesburypartners.com jgranger@hawkesburypartners.com

Micro-X Limited, ABN 21 153 273 735, 1284 South Road, Tonsley, South Australia, 5042, AUSTRALIA

www.micro-x.com